Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Amortizatization of Intangibles (2016 - 2025)

Historic Amortizatization of Intangibles for Rocket Pharmaceuticals (RCKT) over the last 9 years, with Q3 2025 value amounting to $1.7 million.

  • Rocket Pharmaceuticals' Amortizatization of Intangibles fell 919.42% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 million, marking a year-over-year decrease of 2781.84%. This contributed to the annual value of $8.1 million for FY2024, which is 2415.74% down from last year.
  • As of Q3 2025, Rocket Pharmaceuticals' Amortizatization of Intangibles stood at $1.7 million, which was down 919.42% from $2.2 million recorded in Q2 2025.
  • Rocket Pharmaceuticals' Amortizatization of Intangibles' 5-year high stood at $3.3 million during Q4 2023, with a 5-year trough of -$801000.0 in Q4 2021.
  • For the 5-year period, Rocket Pharmaceuticals' Amortizatization of Intangibles averaged around $1.2 million, with its median value being $1.7 million (2025).
  • In the last 5 years, Rocket Pharmaceuticals' Amortizatization of Intangibles crashed by 48629.03% in 2021 and then soared by 156089.74% in 2023.
  • Over the past 5 years, Rocket Pharmaceuticals' Amortizatization of Intangibles (Quarter) stood at -$801000.0 in 2021, then soared by 234.96% to $1.1 million in 2022, then soared by 202.96% to $3.3 million in 2023, then crashed by 62.66% to $1.2 million in 2024, then skyrocketed by 37.29% to $1.7 million in 2025.
  • Its Amortizatization of Intangibles stands at $1.7 million for Q3 2025, versus $2.2 million for Q2 2025 and $2.2 million for Q1 2025.